Department of Clinical Research, Copenhagen University Hospital Amager & Hvidovre, Hvidovre, Denmark.
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Br J Clin Pharmacol. 2023 Jun;89(6):1789-1798. doi: 10.1111/bcp.15639. Epub 2023 Jan 6.
The study's aim is to compare current and new equations for estimating glomerular filtration rate (GFR) based on creatinine, cystatin C, β-trace protein (BTP) and β2 microglobulin (B2M) among patients undergoing major amputation.
This is a secondary analysis of data from a prospective cohort study investigating patients undergoing nontraumatic lower extremity amputation. Estimated GFR (eGFR) was calculated using equations based on creatinine (eGFRcre[2009] and eGFRcre[2021]), cystatin C (eGFRcys), the combination of creatinine and cystatin C (eGFRcomb[2012] and eGFRcomb[2021]) or a panel of all 4 filtration markers (eGFRpanel). Primary outcome was changed in eGFR across amputation according to each equation. Two case studies of prior amputation with GFR measured by 99mTc-DTPA clearance are described to illustrate the relative accuracies of each eGFR equation.
Analysis of the primary outcome included 29 patients (median age 75 years, 31% female). Amputation was associated with a significant decrease in creatinine concentration (-0.09 mg/dL, P = 0.004), corresponding to a significant increase in eGFRcre[2009] (+6.1 mL/min, P = 0.006) and eGFRcre[2021] (+6.3 mL/min, P = 0.006). Change across amputation was not significant for cystatin C, BTP, B2M or equations incorporating these markers (all P > 0.05). In both case studies, eGFRcre[2021] yielded the largest positive bias, eGFRcys yielded the largest negative bias and eGFRcomb[2012] and eGFRcomb[2021] yielded the smallest absolute bias.
Creatinine-based estimates were substantially higher than cystatin C-based estimates before amputation and significantly increased across amputation. Estimates combining creatinine and cystatin were stable across amputation, while the addition of BTP and B2M is unlikely to be clinically relevant.
本研究旨在比较基于肌酐、胱抑素 C、β-痕迹蛋白(BTP)和β2 微球蛋白(B2M)的当前和新的肾小球滤过率(GFR)估计方程在接受大截肢的患者中的应用。
这是一项对前瞻性队列研究数据的二次分析,该研究调查了接受非创伤性下肢截肢的患者。使用基于肌酐的方程(eGFRcre[2009]和 eGFRcre[2021])、胱抑素 C(eGFRcys)、肌酐和胱抑素 C 的组合(eGFRcomb[2012]和 eGFRcomb[2021])或 4 种滤过标志物组合(eGFRpanel)计算估计肾小球滤过率(eGFR)。主要结局是根据每个方程在截肢过程中 eGFR 的变化。描述了两个先前截肢的案例研究,通过 99mTc-DTPA 清除率测量 GFR,以说明每个 eGFR 方程的相对准确性。
对主要结局的分析包括 29 名患者(中位年龄 75 岁,31%为女性)。截肢与肌酐浓度显著下降(-0.09 mg/dL,P=0.004)相关,相应地 eGFRcre[2009](+6.1 mL/min,P=0.006)和 eGFRcre[2021](+6.3 mL/min,P=0.006)显著增加。胱抑素 C、BTP、B2M 或包含这些标志物的方程在截肢过程中变化不显著(均 P>0.05)。在两个案例研究中,eGFRcre[2021]产生的正偏倚最大,eGFRcys 产生的负偏倚最大,eGFRcomb[2012]和 eGFRcomb[2021]产生的绝对偏倚最小。
在截肢前,基于肌酐的估计值明显高于基于胱抑素 C 的估计值,并且在截肢后显著增加。肌酐和胱抑素 C 的组合估计在截肢过程中保持稳定,而添加 BTP 和 B2M 可能没有临床意义。